Vaccine development and production
Ended Definitive Contract Awarded Last action
- Contract number
- W911QY20C0077
- Awardee
-
Novavax Inc. UEI ZXHWXURNS6W8
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $36,042,001
Award facts
- Contract value 100% obligated
- $36,042,001.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Cost No Fee
- Place of performance
- Gaithersburg, MD 20878, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$9,628,658 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $0 | |
| Supplemental Agreement for work within scope | $15,718,275 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $8,000,000 | |
| Original award | $21,952,384 |
About this award
This is a definitive contract awarded by the Department of the Army's Aberdeen Proving Ground Contracting Command to Novavax Inc., a biotechnology company that develops and produces recombinant protein nanoparticle vaccines. The $36,042,001.44 contract is for vaccine development and production related to the COVID-19 response, with a period of performance through December 2022. This contract is not set aside for any specific business type. Novavax has also received Indefinite Delivery Vehicle (IDV) contracts from the Centers for Disease Control and Prevention (CDC) to provide adult and pediatric COVID-19 vaccines, as well as a Federal Supply Schedule contract with the Department of Veterans Affairs to furnish pharmaceuticals and hematology products.
Quick answers
Who was awarded contract W911QY20C0077?
W911QY20C0077 was awarded to Novavax Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on June 4, 2020.
How much is contract W911QY20C0077 worth?
The government has obligated $36,042,001 on W911QY20C0077.
Which agency awarded contract W911QY20C0077?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY20C0077, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911QY20C0077 competed?
The extent of competition for W911QY20C0077 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award